Health News
FDA approves first gene therapy for sickle cell disease
[ad_1]
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
[ad_2]
[ad_1]
The Food and Drug Administration on Friday approved the first-ever gene-editing therapy that uses a cutting-edge technology called CRISPR to treat sickle cell disease. Dr. Jon LaPook has more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
[ad_2]
Lorem ipsum dolor sit amet, consectetur.